Karcinex Diagnostics is an early-stage medical device startup dedicated to providing clinicians and patients with better options for the screening and diagnosis of urological diseases. Our current focus is to increase the accuracy and simplicity of diagnostic procedures for bladder cancer. Presently, there is no recommended method for the early detection of bladder cancer. Karcinex aims to provide the technology that solves this problem. Our device utilizes a novel, noninvasive, and low-energy approach to increase cell count in urine for an enhanced urine cytology test sensitive enough for the screening of bladder cancer. By diagnosing earlier, Karcinex aims to significantly reduce the burden of the disease.
Karcinex was founded in 2012 by biomedical engineers and urological researchers from Johns Hopkins University. Our company brings together a team of passionate engineers and entrepreneurs who are committed to innovation in medicine. This group combines the set of skills and experiences in cancer research, urology, and engineering necessary to develop the most scientifically sound and clinically viable solutions.
Company’s Keywords:
<10
<10000000
<
<2013
Your request has been submitted successfully.
Own or work here?